FDA scientists question Capricor data; Legend CEO steps down
Source ↗
👁 0
💬 0
Capricor shares lost much of their value ahead of a high-stakes advisory committee meeting. Elsewhere, Ying Huang’s resignation extended a stock slide for Legend and AstraZeneca disclosed more pipeline trouble.
Comments (0)